• Join
  • Login
  • Contact

Search abstracts

Design, identification, optimisation and validation of selective casein kinase II(CK2) modulator

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: CBS-010
  • By: SHOEMAKE, Claire ()
  • Co-author(s): Ms Oksana Friggieri, Pharmacy
    Dr Claire Shoemake, Senior Lecturer
  • Abstract:

    The CK2 receptor has been acknowledged as a key contributor to carcinogenesis and has been identified as a druggable target in oncology because its inhibition slows down cellular metabolism. GO289 has been identified as a promising molecule for the mitigation of phosphorylation of circadian proteins and proliferation of malignant cells through CK2 ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses